Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KMTS Kestra Medical Technologies Inc

交易中 03-24 13:33:27 EDT

20.46

+0.87

+4.44%

最高20.86	最低18.87	成交量22.80万
今开19.56	昨收19.59	日振幅10.16%
总市值11.94亿	流通市值6.29亿	总股本5,835万
成交额452.70万	换手率0.74%	流通股本3,074万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KMTS","market":"US","secType":"STK","nameCN":"Kestra Medical Technologies Inc","latestPrice":20.46,"timestamp":1774373599266,"preClose":19.59,"halted":0,"volume":228033,"delay":0,"changeRate":0.04441041347626345,"floatShares":30737300,"shares":58349053,"eps":-2.7601,"marketStatus":"交易中","change":0.87,"latestTime":"03-24 13:33:27 EDT","open":19.56,"high":20.86,"low":18.87,"amount":4526965.387854,"amplitude":0.101582,"askPrice":20.45,"askSize":70,"bidPrice":19.87,"bidSize":225,"shortable":3,"etf":0,"ttmEps":-2.7601,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"listingDate":1741237200000,"exchange":"NASDAQ","adjPreClose":19.59,"postHourTrading":{"tag":"盘后","latestPrice":18.22,"preClose":19.59,"latestTime":"17:54 EDT","volume":6206,"amount":120823.51,"timestamp":1774302863277,"change":-1.37,"changeRate":-0.069934,"amplitude":0.069934},"volumeRatio":0.424237},"requestUrl":"/m/hq/s/KMTS","defaultTab":"news","newsList":[{"id":"1106953096","title":"财报前瞻｜Kestra Medical Technologies Inc本季度营收预期2,286.23万美元，关注亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1106953096","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106953096?lang=zh_cn&edition=full","pubTime":"2026-03-10 10:43","pubTimestamp":1773110606,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc预计将于2026年03月17日发布最新季度财报，市场目光集中于收入小幅抬升与费用弹性带来的亏损收窄迹象。上季度，Kestra Medical Technologies Inc实现收入2,256.50万美元，毛利率50.63%，归属于母公司股东的净亏损为3,278.50万美元，净利率为-145.29%，每股收益为-0.64；财务口径未给出可比期同比数据，无法进行同比对照。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Kestra Medical Technologies Inc本季度营收预期2,286.23万美元，关注亏损收窄","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS"],"gpt_icon":0},{"id":"1123025838","title":"Kestra Medical Technologies 与 Biobeat Technologies 达成战略合作，旨在提升心脏康复期间可穿戴除颤器患者的诊断洞察力","url":"https://stock-news.laohu8.com/highlight/detail?id=1123025838","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123025838?lang=zh_cn&edition=full","pubTime":"2026-01-13 19:06","pubTimestamp":1768302375,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc (以下简称Kestra) 近日宣布，已与 Biobeat Technologies 建立战略合作关系。此次合作的核心目标，是通过整合双方的前沿技术，显著拓展针对正处于心脏康复期的可穿戴除颤器患者的诊断数据与临床洞察。\n这一举措旨在为患者提供更全面、更连续的生理监测，从而优化其康复路径的管理。通过结合Kestra在可穿戴除颤器领域的专业优势与Biobeat先进的监测技术，双方期望能够为临床医生提供更深入、更及时的患者健康状况信息，最终改善患者的治疗结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"1170461554","title":"Kestra Medical Technologies Inc 与 Biobeat 达成协议 含独家许可及对B轮融资500万美元股权投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1170461554","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170461554?lang=zh_cn&edition=full","pubTime":"2026-01-13 19:04","pubTimestamp":1768302261,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc 宣布与 Biobeat 签署一项重要合作协议。该协议的核心条款包括获得一项独家技术许可授权，以及 Kestra 将对 Biobeat 的 B 轮融资进行一笔价值 500 万美元的股权投资。\n此项合作标志着 Kestra 在拓展其医疗技术版图方面迈出了关键一步。独家许可协议将增强 Kestra 的产品组合和技术实力，而股权投资则体现了其对 Biobeat 未来发展潜力的坚定信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"1138955769","title":"异动解读 | Kestra Medical Technologies盘中大涨8.34%，因增发600万股定价23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138955769","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138955769?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:36","pubTimestamp":1764772600,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc（股票代码：KMTS）今日盘中大涨8.34%，引起了市场的广泛关注。消息面上，公司昨日宣布增发600万股普通股的承销公开发行定价为每股23.00美元。这一举措被市场解读为对公司未来发展的信心，从而推动了股价的上涨。增发所得资金将用于业务发展、增聘销售代表、研发投入以及营运资金等用途，进一步增强了投资者对公司的乐观预期。此次增发的定价和规模反映了市场对Kestra Medical Technologies价值的认可，投资者对公司未来的增长潜力持积极态度，带动了股价的强劲表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"1141029470","title":"异动解读 | Kestra Medical Technologies盘前大涨5.22%，因宣布增发600万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1141029470","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141029470?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:46","pubTimestamp":1764769598,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc (KMTS)今日盘前股价大涨5.22%，引起了市场的广泛关注。消息面上，公司宣布增发600万股普通股的承销公开发行定价为每股23.00美元。这一举措可能被市场解读为积极的信号，投资者可能对公司未来的资金用途和增长潜力持乐观态度。此次增发的定价和规模表明公司正在筹集资金以支持其业务发展或战略计划，市场对此反应积极，推动了股价的上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"1117037000","title":"异动解读 | Kestra Medical Technologies盘前大涨5.22%，因增发600万股定价23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117037000","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117037000?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:46","pubTimestamp":1764769594,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc（股票代码：KMTS）今日盘前股价大涨5.22%，引起了市场的广泛关注。消息面上，公司昨日宣布增发600万股普通股的承销公开发行定价为每股23.00美元。这一举措可能被市场解读为对公司未来发展的信心，从而推动了股价的上涨。公开增发通常意味着公司有新的资金需求或扩张计划，而定价的确定往往反映了市场对公司价值的认可。此次增发的定价和规模可能增强了投资者对Kestra Medical Technologies未来增长的预期，进而带动了股价的积极反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KMTS"],"gpt_icon":0},{"id":"1100069600","title":"Kestra：增发600万股普通股的承销公开发行定价为每股23.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100069600","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100069600?lang=zh_cn&edition=full","pubTime":"2025-12-03 11:14","pubTimestamp":1764731649,"startTime":"0","endTime":"0","summary":"Kestra：增发600万股普通股的承销公开发行定价为每股23.00美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2586441022","title":"Kestra Medical Technologies, Ltd.盘中异动 早盘股价大涨5.37%报27.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586441022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586441022?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:55","pubTimestamp":1763999743,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时55分，Kestra Medical Technologies, Ltd.股票出现波动，股价快速拉升5.37%。截至发稿，该股报27.49美元/股，成交量6.1261万股，换手率0.12%，振幅6.69%。Kestra Medical Technologies, Ltd.股票所在的医疗设备行业中，整体涨幅为0.46%。Kestra Medical Technologies, Ltd.公司简介：Kestra Medical Technologies Ltd是一家处于商业阶段的可穿戴医疗设备和数字医疗公司，专注于通过直观、智能和互联的监测和治疗干预技术改变心血管疾病患者的预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235543977cc927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235543977cc927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KMTS","BK4082","SCA"],"gpt_icon":0},{"id":"1183811261","title":"可穿戴除颤器最大规模实地研究证实Kestra的Assure设备具有强效性和安全性表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1183811261","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183811261?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:52","pubTimestamp":1762786334,"startTime":"0","endTime":"0","summary":"可穿戴除颤器最大规模实地研究证实Kestra的Assure设备具有强效性和安全性表现","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"1137168375","title":"Kestra Medical Technologies Inc任命Timothy Moran为首席商务官，强化领导团队助力下一阶段发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1137168375","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137168375?lang=zh_cn&edition=full","pubTime":"2025-10-07 20:03","pubTimestamp":1759838627,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc任命Timothy Moran为首席商务官，强化领导团队助力下一阶段发展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2517174835","title":"可穿戴心脏设备制造商Kestra Medical(KMTS.US)IPO定价17美元/股 上市首日涨逾28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517174835?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:02","pubTimestamp":1741334561,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，可穿戴心脏设备制造商Kestra Medical Technologies以每股17美元的价格发行1190万股股票，高于14 - 16美元的发行价区间，筹资2.02亿美元。Kestra于3月6日(周四)登陆纳斯达克，上市首日收涨28.47%。Kestra正在商业化其心脏康复系统平台，这是一个综合且先进的系统，将监测、治疗、数字健康和患者支持服务整合为一个统一的解决方案。截至2025年1月31日，Kestra的系统已被美国550多家医院积极采用，自2022年8月全面商业化以来，已有超过1.7万名患者使用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KMTS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kestramedical.com","stockEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":-0.2624},{"period":"3month","weight":-0.2889},{"period":"6month","weight":-0.204},{"period":"1year","weight":-0.2145},{"period":"ytd","weight":-0.2613}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kestra Medical Technologies, Ltd.是一家于2021年5月20日根据百慕大法律注册成立的豁免股份有限公司。该公司是一家商业阶段、可穿戴医疗设备和数字医疗保健公司，专注于使用直观、智能和互联的监测和治疗干预技术改变心血管疾病患者的预后。该公司已经开发并正在商业化他们的心脏恢复系统平台，这是一个综合和先进的系统，将监测、治疗、数字健康和患者支持服务整合为一个单一、统一的解决方案。","exchange":"NASDAQ","name":"Kestra Medical Technologies Inc","nameEN":"Kestra Medical Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kestra Medical Technologies Inc(KMTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kestra Medical Technologies Inc,KMTS,Kestra Medical Technologies Inc股票,Kestra Medical Technologies Inc股票老虎,Kestra Medical Technologies Inc股票老虎国际,Kestra Medical Technologies Inc行情,Kestra Medical Technologies Inc股票行情,Kestra Medical Technologies Inc股价,Kestra Medical Technologies Inc股市,Kestra Medical Technologies Inc股票价格,Kestra Medical Technologies Inc股票交易,Kestra Medical Technologies Inc股票购买,Kestra Medical Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kestra Medical Technologies Inc(KMTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kestra Medical Technologies Inc(KMTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}